Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)
Status:
Completed
Trial end date:
2019-08-21
Target enrollment:
Participant gender:
Summary
This is a single-center, open-label study to evaluate the efficacy of AKCEA-ANGPTL3-LRx for
reduction of fasting triglycerides in participants with familial partial lipodystrophy.